Ellsworth Advisors LLC Makes New $809,000 Investment in Agilon Health, Inc. $AGL

Ellsworth Advisors LLC acquired a new position in shares of Agilon Health, Inc. (NYSE:AGL) in the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor acquired 10,161 shares of the company’s stock, valued at approximately $809,000. Ellsworth Advisors LLC owned 0.06% of Agilon Health at the end of the most recent quarter.

A number of other hedge funds and other institutional investors have also bought and sold shares of the company. State of Alaska Department of Revenue bought a new position in Agilon Health in the 3rd quarter worth $64,000. Allworth Financial LP bought a new stake in Agilon Health during the second quarter valued at about $114,000. Proficio Capital Partners LLC bought a new stake in Agilon Health during the second quarter valued at about $210,000. The Manufacturers Life Insurance Company bought a new stake in Agilon Health during the second quarter valued at about $355,000. Finally, Integrated Wealth Concepts LLC bought a new stake in Agilon Health during the second quarter valued at about $384,000.

Analysts Set New Price Targets

Several equities research analysts have recently issued reports on the company. JPMorgan Chase & Co. raised their price target on Agilon Health from $31.00 to $85.00 and gave the company an “underweight” rating in a research report on Monday, August 24th. Barclays set a $111.00 price objective on Agilon Health and gave the stock an “equal weight” rating in a research report on Thursday, August 6th. Citigroup raised Agilon Health from a “sell” rating to a “neutral” rating and boosted their price objective for the stock from $105.00 to $115.00 in a research report on Monday, August 10th. Sanford C. Bernstein raised Agilon Health from a “market perform” rating to an “outperform” rating and raised their target price for the company from $86.00 to $125.00 in a report on Tuesday, September 15th. Finally, Weiss Ratings reaffirmed a “sell (e+)” rating on shares of Agilon Health in a research report on Monday, August 24th. Six research analysts have rated the stock with a Buy rating, seven have assigned a Hold rating and two have assigned a Sell rating to the company. According to MarketBeat.com, the stock currently has a consensus rating of “Hold” and an average price target of $102.25.

Agilon Health Trading Up 0.8%

Shares of AGL stock opened at $88.09 on Friday. The stock has a market cap of $1.48 billion, a price-to-earnings ratio of -6.17 and a beta of 2.98. The company has a debt-to-equity ratio of 0.07, a quick ratio of 1.08 and a current ratio of 1.08. Agilon Health, Inc. has a 52-week low of $7.48 and a 52-week high of $133.04. The firm has a fifty day moving average of $88.63 and a 200-day moving average of $81.54.

Agilon Health (NYSE:AGL) last released its quarterly earnings data on Wednesday, August 5th. The company reported $1.04 earnings per share for the quarter, beating analysts’ consensus estimates of $0.14 by $0.90. The company had revenue of $1.49 billion for the quarter, compared to the consensus estimate of $1.45 billion. Agilon Health had a negative return on equity of 119.38% and a negative net margin of 3.92%. On average, equities research analysts forecast that Agilon Health, Inc. will post -2.90 earnings per share for the current fiscal year.

About Agilon Health

Agilon Health, Inc is a healthcare company that helps primary care physicians transition from traditional fee-for-service medicine to value-based care. The company primarily works with independent physician practices that serve older adults, particularly Medicare Advantage members, with the goal of improving care coordination, patient outcomes and the overall healthcare experience.

Agilon provides a technology and services platform designed to support population health management. Its offerings include data analytics, clinical and administrative workflows, practice management support, care coordination resources and assistance with payer contracting.